$7.44
-0.02-0.27%
Pre-Market: 7:32 AM EDT
Comments
Loading...
Actuate Therapeutics Stock Guidance | NASDAQ:ACTU | Benzinga
Actuate Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actuate Therapeutics Inc (ACTU) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Actuate Therapeutics (ACTU)?
There have been no specific sales or earnings guidance reported for Actuate Therapeutics in recent months.
Browse guidance and forecast on all stocks.